Literature DB >> 9223484

Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins.

T Yasugi1, M Vidal, H Sakai, P M Howley, J D Benson.   

Abstract

Random mutagenesis of human papillomavirus type 16 (HPV16) E1 was used to generate E1 missense mutants defective for interaction with either hUBC9 or 16E1-BP, two cDNAs encoding proteins that have been identified by their ability to interact with HPV16 E1 in two-hybrid assays. hUBC9, the human counterpart of Saccharomyces cerevisiae UBC9, is a ubiquitin-conjugating enzyme known to be involved in cell cycle progression. 16E1-BP encodes a protein of no known function but does contain an ATPase signature motif. Eight hUBC9 or 16E1-BP interaction-defective HPV16 E1 missense mutants were identified and characterized for origin-dependent transient DNA replication, ATPase activity, and various protein-protein interaction phenotypes. Six of these mutant E1 proteins were significantly impaired for replication. Among these, two classes of replication-defective HPV16 E1 missense mutants were observed. One class, represented by the S330R replication-defective mutant (containing an S-to-R change at position 330), remained competent for all protein-protein interactions tested, with the exception of hUBC9 association. Furthermore, this mutant, unlike the other replication-defective HPV16 E1 missense mutants, had a strong dominant negative replication phenotype in transient-replication assays. The other class, represented by five of the missense mutants, was defective for multiple protein-protein interactions, usually including, but not limited to, the interaction defect for which each mutant was originally selected. In many cases, a single missense mutation in one region of HPV16 E1 had pleiotropic effects, even upon activities thought to be associated with other domains of HPV16 E1. This suggests that E1 proteins are not modular but may instead be composed of multiple structurally and/or functionally interdependent domains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223484      PMCID: PMC191850     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Activation of BPV-1 replication in vitro by the transcription factor E2.

Authors:  L Yang; R Li; I J Mohr; R Clark; M R Botchan
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

2.  The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase.

Authors:  L Yang; I Mohr; E Fouts; D A Lim; M Nohaile; M Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

3.  DNA-binding domain of bovine papillomavirus type 1 E1 helicase: structural and functional aspects.

Authors:  L K Thorner; D A Lim; M R Botchan
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

4.  Bovine papillomavirus E1 protein can, by itself, efficiently drive multiple rounds of DNA synthesis in vitro.

Authors:  C Bonne-Andrea; S Santucci; P Clertant
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  G2 cyclins are required for the degradation of G1 cyclins in yeast.

Authors:  M Blondel; C Mann
Journal:  Nature       Date:  1996-11-21       Impact factor: 49.962

6.  Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site.

Authors:  M Lusky; J Hurwitz; Y S Seo
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

7.  Repression of bovine papillomavirus type 1 transcription by the E1 replication protein.

Authors:  A B Sandler; S B Vande Pol; B A Spalholz
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Replication of human papillomavirus (HPV) DNAs supported by the HPV type 18 E1 and E2 proteins.

Authors:  F Sverdrup; S A Khan
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin.

Authors:  Y S Seo; F Müller; M Lusky; E Gibbs; H Y Kim; B Phillips; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  The bovine papillomavirus type 1 (BPV1) replication protein E1 modulates transcriptional activation by interacting with BPV1 E2.

Authors:  M A Le Moal; M Yaniv; F Thierry
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more
  21 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Authors:  Alexandra Côté-Martin; Cary Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michaël Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 3.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 4.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

5.  Evidence for a structural relationship between BRCT domains and the helicase domains of the replication initiators encoded by the Polyomaviridae and Papillomaviridae families of DNA tumor viruses.

Authors:  Anuradha Kumar; Woo S Joo; Gretchen Meinke; Stephanie Moine; Elena N Naumova; Peter A Bullock
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

6.  Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response.

Authors:  Amélie Fradet-Turcotte; Fanny Bergeron-Labrecque; Cary A Moody; Michaël Lehoux; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

7.  Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint-silencing protein.

Authors:  Kexi Wang; Brianne Sturt-Gillespie; James C Hittle; Dawn Macdonald; Gordon K Chan; Tim J Yen; Song-Tao Liu
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

8.  Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.

Authors:  Amélie Fradet-Turcotte; Karine Brault; Steve Titolo; Peter M Howley; Jacques Archambault
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

Review 9.  Targeting human papillomavirus genome replication for antiviral drug discovery.

Authors:  Jacques Archambault; Thomas Melendy
Journal:  Antivir Ther       Date:  2013-04-24

10.  Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer.

Authors:  Shi-Feng Xu; Zhi-Hai Peng; Da-Peng Li; Guo-Qiang Qiu; Fang Zhang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.